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CHAPTER 8
Psychological  Treatments  for  Dermatological
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Abstract:  The  impact  of  dermatological  conditions  on  a  patient's  life  is  frequently
underestimated. Patients with skin conditions experience several physical complaints,
including itch, pain and fatigue. Furthermore, in comparison to the general population,
patients  report  a  decreased  psychological  well-being,  lowered  quality  of  life  and
feelings  of  stigmatization  and  shame.  Psychological  treatments  are  widely  used  in
addition to regular dermatological treatments to improve physical and psychological
functioning  of  patients  with  chronic  skin  conditions.  These  treatments  are  usually
aimed at changing the psychosocial factors that can influence the onset and/or course of
skin conditions, such as dysfunctional coping behaviors, itch-scratching problems and
stress.  There  are  unimodal  interventions  in  which  single  treatments  are  used,  for
example psychoeducation or relaxation exercises, and multimodal treatments in which
a variety of different interventions are applied based on cognitive-behavioral therapy
and  self-management  principles.  Furthermore,  a  distinction  can  be  made  between
interventions that focus primarily on skin-related psychosocial problems, interventions
that  focus  on  itch-scratching  problems,  and  interventions  that  are  focused  on
psychiatric problems in the dermatological practice. This chapter gives an overview on
the  psychosocial  factors  relevant  for  dermatological  conditions,  relevant  diagnostic
methods and the content and scientific evidence of specific psychological treatments in
these different categories.
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INTRODUCTION
The  impact  of  skin  conditions  on  a  patient's  everyday  life  is  frequently
underestimated. Although the influence of psychological factors on the skin has
been recognized since a long time, systematic research on psychological factors
and treatments  has  only begun in  the  last  decades.  Research shows that  people
with skin conditions experience more physical symptoms, such as itch, pain and
fatigue than the general population [1]. Patients additionally report more anxiety,
tension  and  depressive  feelings,  and  experience  social  restrictions  [2  -  4].
Psychological treatments have consequently been regularly proposed as possible
added  benefit  for  the  regular  dermatological  treatments.  Based  on  the  existing
research  evidence  focusing  particularly  on  highly  prevalent  chronic  skin
conditions,  this  chapter  focuses  on  the  psychosocial  factors  relevant  for
dermatological  conditions  and  their  impact  on  daily  life,  relevant  diagnostic
methods  and  psychological  treatments.
PREVALENT  PROBLEMS  IN  PATIENTS  WITH  DERMATOLOGICAL
CONDITIONS
Skin conditions are generally characterized by their fluctuating course and they
are  often  accompanied  with  physical  complaints  such  as  itch,  desquamation  or
pain. Research shows that chronic skin conditions, such as psoriasis and eczema,
are  accompanied  by  physical,  emotional  and  social  problems  and  can  lead  to
multiple restrictions in everyday life [5]. Patients report decreased psychological
well-being and lower quality of life compared to the general population [3, 6, 7].
For  20  to  40  percent  of  this  group,  symptoms  are  so  severe  that  they  are
considered a risk group for long-term adjustment problems which require further
treatment [4]. The decreased psychosocial well-being can in turn negatively affect
the skin condition; for example, patients with psoriasis who also have a high level
of psychological distress benefit less from treatments such as phototherapy [8].
Patients  with  chronic  skin  conditions  often  state  that  ‘itch  is  worse  than  pain’.
Accordingly, itch is the most prominent complaint in most skin conditions. More
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than half  of  the patients  with chronic skin conditions report  to  be experiencing
symptoms of itch [1, 9]. The definition of itch, ‘an unpleasant sensation provoking
the desire to scratch’, implies the strong correlation between itch and scratching.
Frequent scratching can however lead to skin damage which can in turn aggravate
skin conditions [9]. In many patients, scratching leads to relief in the short-term,
while feelings of helplessness, shame and guilt play a big role in the long-term.
Reactions  from  the  environment  towards  the  scratching  behavior  (‘Could  you
please stop scratching yourself’) can increase these feelings and cause irritation
and tensions. Many patients especially suffer from itch at night, leading to sleep
problems, chronic fatigue, concentration problems and increased irritability during
the day. Over time this can lead to increased avoidance of everyday activities and
in  the  longer  term to  depressive  moods  [3].  Accordingly,  patients  with  chronic
itch report lower psychological and social well-being than the general population
[2  -  4].  Besides  itch,  skin  conditions  can  also  be  accompanied  by  pain  [1],  for
example  in  patients  with  chronic  ulcera.  In  addition,  eczemas  or  open  wounds
caused by scratching can also cause painful fissures in the skin.
Patients with chronic skin conditions additionally report more restrictions in social
activities, work and leisure than the general population. Multiple factors can play
a role in this. Medical treatments of skin conditions are often quite time intensive,
for example when an ointment has to be applied to the whole body several times a
day. Additionally patients report feeling restricted by the effect of ointments on
their clothes and by the smell of certain ointments such as coal tar ointments. Due
to the visibility of skin conditions, many patients experience social stigmatization,
shame and social anxiety [3, 10, 11]. A study by Ginsburg and Link [12] revealed
that about 20 percent of patients with psoriasis experienced being sent away from
sports,  hairdressers  or  swimming  facilities  because  of  their  skin  condition.
However,  the  proportion  of  patients  that  suffer  from  ‘the  experience  of
stigmatization’ is far greater. Indeed, Lu et al. [13] found that about 80 percent of
patients  with psoriasis  and atopic  eczema felt  stigmatized by others  because of
their skin disease at least once, 30 percent of which severely. The experience of
stigmatization  is  one  of  the  strongest  determinants  of  perceived  restrictions  in
everyday life [14, 15] and can lead to decreased self-confidence and feelings of
shame. These feelings can cause people to isolate themselves and avoid being in
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public (for example, at restaurants, sports centers or beaches). Additionally, such
feelings  can  lead  to  fear  of  interacting  with  others,  which  in  turn  can  affect
interpersonal  relationships  [16].
Certain skin conditions that develop at early age, for example atopic eczema, or
develop at a certain developmental phase, such as acne, can affect psychosocial
development. Children and adolescents who suffer from skin conditions report a
lower quality of  life  compared to peers with other conditions that  occur during
childhood, such as asthma and diabetes [17]. Apart from complaints of itch and
pain this group can also experience emotional and social problems, such as shame,
sleep  problems,  restrictions  in  hobbies  and  restrictions  in  entering  into
relationships [17, 18]. Additionally, chronic skin conditions do not only affect the
child but the whole family, so that parents are found to have lower quality of life
and higher rates of psychological distress [19].
A relatively rare category of skin conditions are those in which the complaints are
considered mainly psychogenic. Conditions which are characterized by self-harm
fall  into  this  category,  for  example  factitious  disorder,  where  patients  hurt
themselves  systematically  and  repeatedly  in  order  to  be  diagnosed  with  a  skin
condition (this condition is also known as Münchausen’s syndrome or dermatitis
artefacta)  [20,  21].  Furthermore  there  are  several  compulsive  disorders  that
express themselves on the skin, such as trichotillomania (the compulsion to pull
out one’s hair and eyebrows) and skin picking disorder or dermatillomania (the
compulsion to continually pick or rub one’s skin). Conditions such as delusional
infestation, in which patients strongly believe that they are infested by parasites,
also fall into this category. Patients suffering from this condition often experience
itch  and/or  pain  as  well  as  wounded  skin  caused  by  scratching.  Despite  the
psychiatric nature of these conditions, patients suffering from them often visit the
dermatologist  because  of  their  skin  complaints.  In  recent  years  more  and more
attention  has  been  paid  to  body  dysmorphic  disorder,  in  which  patients  are
preoccupied with a supposedly objective deficiency in their appearance, which is
often related to their skin. Obsessive preoccupation with one’s skin, for example
frequently looking at it in the mirror, can also be experienced by patients with for
example acne vulgaris or alopecia (excessive hair loss).
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PSYCHOSOCIAL FACTORS IN DERMATOLOGICAL CONDITIONS
On  average  patients  with  skin  conditions  have  a  lower  quality  of  life  than  the
general  population.  However,  there  are  large  differences  between  individual
patients. As in other somatic conditions these differences cannot be explained by
the  severity  of  the  skin  condition  alone.  Psychosocial  factors  can  influence  the
onset and/ or the course of certain skin conditions.
About two-thirds of patients with psoriasis and atopic eczema report that stress
influences the course of their condition [3, 22, 23]. This influence of stress on the
skin  is  a  possible  starting  point  for  psychological  interventions.  For  example,
improving  stress  coping  mechanisms  by  means  of  stress  management  trainings
could affect the severity of a skin condition. The relationship between stress and
the course of a condition could in part be explained by the role that the immune
system  plays  in  chronic  inflammatory  skin  diseases.  More  specifically,
neuroendocrine and immune mechanisms (for example cortisol and cytokines) can
be  influenced  by  stress  and  can  in  turn  influence  chronic  skin-related
inflammatory activity [22, 24]. Indeed, several prospective studies found a link
between stressors and the course of conditions [23 - 25]. Accordingly, in patients
with  atopic  eczema,  subjective  stress  proved  to  predict  disease  severity  on  the
following day [26]. Additionally, in patients with psoriasis, high levels of daily
stressors were associated with an increase in disease severity and itch four weeks
later  [24,  25].  Stressors  can  influence  wound  healing  [27],  although  this
relationship  has  not  been  studied  in  patients  with  skin  conditions.  Some
correlations  have  also  been  found  between  for  example  stressors,  cortisol  and
indicators of disease severity [7, 22, 24], however future research is necessary to
further investigate these relationships. Stress influences skin conditions, and skin
conditions  cause  stress  for  the  patient  resulting  in  a  vicious  cycle.  Itch  is
correlated with an increased activity of the autonomic and central nervous system
which expresses itself as increased anxiety. Also the visibility of the condition and
the  perceived  stigmatization  is  a  significant  stressor  for  patients.  Additionally,
many patients report that time-intensive treatments and their impact on everyday
life can lead to stressful situations.
An important mediating factor between stressors and disease outcomes is the way
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patients cope with their condition, including their opinions and attitudes about it,
and  the  perceived  support  from  their  environment.  Many  patients  with  skin
conditions  experience  feelings  of  helplessness  when  trying  to  cope  with  their
condition. In particular the unpredictable course of a skin condition and the lack
of control can make coping more difficult. In line with research on other chronic
physical conditions there is some indication that a more passive, avoiding coping
style  and  catastrophizing  cognitions  can  negatively  affect  the  course  of  a
condition and the success  of  a  treatment  [7,  8,  25,  28].  Furthermore,  studies  in
people  with  atopic  eczema  and  psoriasis  have  revealed  connections  between
perceived helplessness in coping with the condition and decreased physical and
psychological  well-being  [2].  In  many  physical  conditions,  perceived  social
support  is  an  important  predictor  of  long-term  functioning.  Considering  the
visibility of skin conditions and their impact on daily life these findings could be
especially relevant for skin conditions. However, research on this relationship has
so far received relatively little attention [2]. Health behavior can also affect the
course of skin conditions. Given that daily skin care with ointments requires a lot
of self-reliance, time and effort, following treatment prescriptions is often difficult
for dermatological patients. Research shows that approximately 44% of patients
do  not  follow  their  treatment  prescriptions  exactly  [29,  30].  Besides  lack  of
adherence,  lifestyle  factors  can  also  affect  the  course  of  a  chronic  physical
condition. There are, for example, indications that in patients with chronic ulcer
(open wound),  healing of  venous ulcers  can be slowed by lack of  exercise  and
obesity [31].
Increasing attention is paid to scratching behavior as a perpetuating factor of itch
in chronic skin conditions [3, 9]. Primarily, scratching is an automatic action to
reduce itch. Frequent scratching, however, leads to skin damage and the healing
process of these scratching wounds is again accompanied by itch, which may lead
to a vicious cycle of itch-scratching problems. Additionally, research in learning
theory  shows that  scratching  can  lead  to  a  generalized  conditioned  response  to
stressors  and  other  environmental  stimuli  in  the  long  term  [9].  In  these  cases,
people scratch not only in response to itch but also as a reaction to stress, anxiety,
boredom  or  other  stimuli  that  have  been  associated  with  scratching  over  time.
This  scratching  behavior  can  be  aggravated  by  reinforcing  factors  from  the
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environment. For example, the attention that a child receives from his/her parents
can contribute to maintaining the problematic scratching behavior. Through the
effects of skin damage due to scratching behavior, this itch-scratch problem can
have a significant and persisting influence on the severity of the disease and the
effects of dermatological treatments [9, 32].
PSYCHOLOGICAL  ASSESSMENT  AND  DIAGNOSTICS  IN
DERMATOLOGICAL CONDITIONS
Referral  to  a  psychologist  or  other  psychosocial  counselor  is  common  when
dermatological  interventions  have  insufficient  results,  or  when  there  is  a
possibility of psychosocial problems. In standardized interviews, it is important to
identify  and  assess  psychosocial  symptoms  as  well  as  those  factors  that  can
influence the skin condition, such as stressors, health behavior, adherence, social
anxiety, itch-scratching problems, or overall coping. Standardized questionnaires
can be used in support of the information obtained from the interview in order to
determine the right treatment. Several questionnaires with adequate psychometric
qualities  are available to identify the overall  physical,  psychological  and social
well-being of patients with skin conditions. The most widely used questionnaire is
the  Dermatological  Life  Quality  Index  (DLQI)  [33],  a  one-dimensional,
dermatology-specific  quality  of  life  questionnaire  consisting  of  ten  items  for
which  extensive  normative  data  has  been  published  for  a  wide  variety  of  skin
conditions  [33].  The  more  extensive  Skindex  [34]  is  a  questionnaire  which
assesses the physical, emotional and social functioning of a patient with the help
of  several  scales,  and  which  is  validated  for  various  chronic  skin  conditions.
Additionally, questionnaires for other physical conditions have been adapted to
assess chronic skin conditions. For example, the Impact of Chronic Skin Disease
on  Daily  Life  (ISDL)  [35]  which  makes  it  possible  to  compare  how  different
physical  conditions impact  psychological  and social  well-being.  A widely used
instrument  to  assess  the  quality  of  life  in  children  with  skin  conditions  is  the
Children’s  Dermatology Life  Quality  Index (CDLQI)  [36].  In  addition to  these
questionnaires about skin conditions, generic instruments are frequently used such
as the Short Form Health Status Survey (SF-36) [37] which can be used to assess
the physical and psychological quality of life in people with chronic conditions. A
disadvantage  of  generic  questionnaires  is  that  they  do  not  measure  specific
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physical effects of skin conditions, such as itch, and do not make use of available
instruments which identify skin-related cognitive and behavioral factors.
Furthermore,  instruments  are  available  that  measure  skin-related  cognitive  and
behavioral  factors.  The  above  mentioned  ISDL,  for  example,  also  measures
behavioral  factors  such  as  itch-scratching  problems,  illness  cognitions  of
perceived helplessness  and acceptance and the amount  of  social  support.  Other
similar questionnaires are the Itching Cognitions Questionnaire (ICQ) [38 - 40]
which assesses a variety of cognitions about itch such as catastrophizing and the
Adjustment to Chronic Skin Diseases Questionnaire (ACS) [41] which measure
different skin-related illness cognitions and coping strategies for coping with skin
conditions. Additionally, specific questionnaires have been developed to measure
the  degree  of  stigmatization  [35,  42,  43].  Similar  instruments  have  also  been
developed for children and adolescents with atopic eczema [44]. Finally, stressors
and personality traits are usually measured with generic questionnaires that have
been validated for various chronic somatic and mental conditions.
PSYCHOLOGICAL  TREATMENTS  FOR  PATIENTS  WITH
DERMATOLOGICAL CONDITIONS
Psychological  treatments  are  widely  used  to  improve  the  psychosocial  and
physical  well-being  of  people  with  chronic  skin  conditions  [3,  22].  These
interventions vary in the degree to which they attempt to change behaviors. There
are  unimodal  interventions  in  which  single  treatments  are  used,  for  example
psycho-education or relaxation exercises, and multimodal treatments in which a
variety  of  different  interventions  are  applied  based  on  cognitive-behavioral
therapy  and  self-management  principles.  These  interventions  usually  focus  on
how  patients  cope  with  disease-related  factors  such  as  itch,  scratching  or
experienced  stigmatization.  In  this,  a  distinction  can  be  made  between
interventions  that  focus  primarily  on  skin-related  psychosocial  problems,
interventions  that  focus  on  itch-scratching  problems,  and  interventions  that  are
focused on psychiatric problems in the dermatological practice. The content of,
and scientific evidence for these specific psychological treatments in the different
categories will be described below.
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Treatments of Skin-Related Psychosocial Problems
Important skin-related factors in chronic skin conditions that can be targeted by
psychological treatments are social anxiety, depression, perceived stigmatization
and dysfunctional coping strategies, such as avoidance behavior, acceptance and
adjustment problems. In these cases, cognitive-behavioral methods are used that
have been proven effective for these kinds of problems [3, 22, 45, 46].
Unimodal  treatments  that  consist  of  psycho-education have so far  been used to
target psychosocial problems in children and adolescents with skin-conditions and
their  parents.  A review of randomized controlled trials  in patients  with chronic
skin  conditions  reveals  that  in  particular  interventions  involving  a  multidiscip-
linary team and several meetings, participants reported an improved quality of life
and reduced disease severity [47]. One example is the intervention of Staab et al.
[48] in which a distinction was made between different age groups, and children
with  atopic  eczema  and  their  parents  were  provided  with  a  structured  psycho-
education, consisting of six sessions which were led by a multidisciplinary team
(among others a dermatologist, a psychologist, a nurse and a dietician). Following
this intervention, patients reported reduced disease severity. Similar results were
found with educational interventions in adults [47].
Because  of  the  connection  between  stress-related  factors  and  skin  conditions,
relaxation exercises and stress-management interventions are frequently used in
the  treatment  of  skin  conditions.  Among  the  feasible  exercises  are  various
relaxation  techniques  such  as  progressive  relaxation,  autogenic  training,
visualization  exercises,  biofeedback,  but  also  multimodal  interventions  which
integrate,  among  others,  cognitive  restructuring  techniques  and  methods  which
strengthen problem-solving skills. The rationale behind such interventions is that
by changing the stress response one can also influence inflammatory activity and
diseases  severity.  A  recent  study  found  that  patients  with  atopic  eczema  that
participated  in  a  short-term  stress  management  training  indeed  showed  a
decreased cortisol response during exposure to a psychosocial stressor compared
to the control group [49]. However, in this study no effect on the severity of the
eczema was found, possibly because the sample was too small or the follow-up
too short. There are also indications that patients with psoriasis and atopic eczema
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benefit from stress-focused relaxation therapy [50], which resulted in decreased
disease severity in patients with atopic eczema [51] and a reduction of required
phototherapy sessions in patients with psoriasis [52].
Especially  in  patients  with  psoriasis  and  atopic  eczema,  multimodal  cognitive-
behavioral treatments have been shown to be effective, for example in improving
emotional functioning, reducing disease severity and itching, and increasing the
effectiveness  of  regular  dermatological  treatments.  An  example  of  these
treatments  is  short-term  cognitive-behavioral  group  therapy  in  patients  with
psoriasis.  In  addition  to  information  about  the  diseases,  this  short-term  group
therapy uses stress management, relaxation therapy and cognitive therapy which
focuses on disease-related attitudes, social anxiety and perceived stigmatization.
In one study patients reported reduced disease severity, less disease-related stress,
anxiety and depression compared to the control group directly after the treatment
and at a follow-up assessment six month later [53]. Also, a treatment consisting of
twelve  sessions  focusing  on  education,  relaxation,  techniques  to  control
scratching, which made use of self-control techniques and habit reversal, stress-
management and improvement of communication, was effective in improving the
severity of the skin condition [51].
A new development is the application of psychological interventions in the form
of education, self-management and cognitive behavioral therapy via the Internet
(eHealth),  which  is  increasingly  used  in  cognitive-behavioral  treatments  of
patients with chronic somatic conditions, including skin diseases [54, 55]. eHealth
has several important advantages, such as a greater reach of care and better access
to  care,  less  time  consumption  and  travel  costs  for  the  patient  and  a  great
flexibility  for  therapist  and  patient.  There  are  indications  that  eHealth
interventions can be as effective as face to face treatments for various physical
ailments [56]. Additionally, psychological interventions focused on mindfulness
and acceptance, which are increasingly used in treating chronic conditions, offer
promising possibilities for the psychological treatment of skin conditions [52].
Furthermore,  multimodal  interventions  for  children  have  been  developed  that
make  use  of  education  in  combination  with  cognitive  behavioral  therapy  and
relaxation therapy [57]. For example, an intervention focused on education, stress
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management  and improvement  of  social  skills  in  children and adolescents  with
psoriasis  proved  effective  in  improving  skin  complaints,  self-image  and  social
constraints  [58].  An example  is  the  Supportive  Program for  Education,  Coping
and Training of Parents and Children with Psoriasis and Eczema (SPECTRUM), a
multidisciplinary group treatment for children with psoriasis and eczema and their
parents. During four meetings led by a dermatologist, a clinical psychologist, and
a nurse, it is attempted to increase the self-reliance of children and their parents in
dealing with the condition [59].
Treatments of Itch-Scratching Problems
A considerable amount of research has been conducted on the effects of cognitive
behavioral treatments specifically focused on itch-scratching problems. In clinical
practice,  these  treatments  are  frequently  applied  in  combination  with
psychological  treatments  for  skin-related  problems.  The  primary  goal  of
treatments for itch-scratching problems is to improve the way patients cope with
itch and to decrease scratching behavior. In the long-term, it is also expected that
itch and the severity  of  the skin disease is  reduced and patients’  quality  of  life
improved. The treatments thus have the following two areas of focus: dealing with
itch, and dealing with scratching. In dealing with itch, attention has to be paid to
the  regular  application  of  skin  care  routines  (for  example,  application  of
ointments),  avoidance  of  itch-triggering  stimuli  or  situations  (for  example
transpiration,  in  many  skin  conditions)  and  the  application  of  itch-  and  stress-
decreasing  measures  (for  example,  relaxation  exercises).  In  dealing  with
scratching,  raising  awareness  of  scratching  habits  (for  example,  through
registration  of  scratching  behavior)  takes  a  central  role  and  patients  are  taught
different methods to control scratching. The best known method for controlling
scratching is ‘habit reversal’ in which patients learn to replace scratching with an
alternative behavior [60]. A basic principle of these treatments is to increase the
responsibility and autonomy of the patient in dealing with itch and scratching. For
example, through education and registration exercises, patients become aware of
early signals of skin deterioration (for example, more itch, scales on the skin, red
skin). Subsequently, they try to recognize these signals at an early stage in their
daily  lives  in  order  to  take  appropriate  action  (for  example,  applying  more
ointments, protecting the skin by using bandages, adding more relaxation to daily
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lives),  with which further aggravation can be prevented.  In case of  very severe
itch, this intervention can also be combined with pharmacological therapies, such
as antihistamines or antidepressants in a very low dosage [61].
Research mainly focuses on multimodal interventions that proved to be effective
in reducing disease activity and/ or reducing the degree of itch and scratching in
patients with atopic eczema or other chronic skin conditions in adults,  children
and adolescents  [32,  40,  48,  51].  The active mechanisms of  these interventions
have  so  far  received  little  attention.  It  is  however  known,  that  in  patients  with
atopic eczema scratch-management methods including habit reversal are effective
[62]. Regarding the duration of the treatment, there are indications that in addition
to  the  proven  effective  treatments  that  include  twelve  meetings  [51],  research
suggests that a short-term multidisciplinary group treatment of five meetings can
have clinically significant effects in the long-term [32]. The training was provided
by  a  cognitive  behavioral  therapist  and  a  specialized  nurse,  using  the
aforementioned  combination  of  methods  aimed  at  reducing  itch-scratching
problems  [32].
Treatments of Psychiatric Problems in Dermatological Practice
In patients with psychiatric problems and severe psychopathology, such as self-
inflicted  skin  lesions  in  factitious  disorder  (dermatitis  artefacta),  delusional
infestation, trichotillomania, skin picking disorder and body dysmorphic disorder,
the nature of the condition implies that psychological treatments tend to be more
complex  and  lengthy.  In  addition  to  that,  the  referral  to  the  psychologist  or
psychiatrist  can be a significant challenge, especially in patients with factitious
disorder,  delusional  infestation  or  body  dysmorphic  disorder,  who  can  often
experience  this  as  a  sign  of  lack  of  understanding.  In  these  cases,  a
multidisciplinary  psychodermatological  approach  of  the  dermatologist  and  the
psychologist/psychiatrist is critical.
For some conditions, it is known that patients benefit from cognitive-behavioral
therapy.  For  example in  patients  with  trichotillomania,  behavioral  therapies  for
impulse control, such as habit reversal, have been applied with promising results
[63].  Also  for  skin  picking  (dermatillomania)  effective  treatments  have  been
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developed,  which  use  among  other  things  habit  reversal  and  cognitive
restructuring  techniques  [64,  65].  For  body  dysmorphic  disorder,  effective
behavioral  therapies  have  been  developed,  which  focus  on  exposure  to  (fear
triggering) social stimuli, response prevention (for example looking at oneself in
the  mirror,  omitting  superfluous  make-up)  and  changing  irrational  beliefs  and
cognitions about one’s own appearance [66, 67].
In  conditions  that  have  not  been  researched  systematically  yet,  such  as  self-
inflicted  lesions  in  factitious  disorder,  cognitive-behavioral  approaches  are
advised  in  the  medical  context,  aimed  at  reducing  or  eliminating  self-injurious
behavior. In these cases, initial attention has to be paid to building trust between
the patient and the dermatologist. The consulting psychologist or psychiatrist is
present  in  the  background  to  carefully  assess  at  which  stage  of  the  therapy
confrontation  is  appropriate.  It  is  important  that  a  neutral  attitude  is  adopted
towards the self-injurious behavior. In most cases, a psychotherapeutic treatment
is  focused  on,  among  other  things,  elucidating  the  possible  functions  of  this
behavior. Learning new coping strategies is necessary to eliminate self-injurious
behavior  [20].  Especially  in  delusions  such  as  delusional  infestation,  these
treatments  tend  to  be  combined  with  pharmacotherapy  [3,  22].
CONCLUSION
Considering  the  high  prevalence  of  physical,  emotional  and  social  problems in
patients with skin conditions, it is crucial that these problems are recognized at an
early  stage,  in  order  to  provide  additional  psychological  care  if  necessary.
However, in the clinical practice of dermatological consultation, limited attention
is paid to potential psychosocial consequences of skin conditions and availability
of  multidisciplinary  approaches  focusing  on  systematic  screening  and
corresponding  treatments  are  only  incidental  [16,  68].  It  is  therefore  of  great
importance that increased attention is paid to psychological research and clinical
applications in the field of dermatology, such as the implementation of screening
instruments in dermatological practice. Also, further development, evaluation and
implementation  of  psychological  interventions  for  skin-related  problems,  itch-
scratching  problems  and  psychiatric  problems  in  dermatological  practice  is
important,  as  the  existing  evidence  shows  promising  results  for  physical  and
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psychological functioning in skin patients [46]. Applications through the Internet
also offer promising starting points to further facilitate the psychodermatological
approach [54 - 56]. In addition, more research is needed to further elucidate the
possible  interactions  between  psychological  and  skin-related  (inflammatory-)
mechanisms,  which  will  provide  possible  starting  points  to  further  specify
psychological  and  psychopharmocological  interventions.
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